Research
Our current interests
Join Our Team
Our laboratory seeks to improve cancer treatment through translational research bridging tumor biology, immunology, and clinical oncology. A major focus is developing therapeutic cancer vaccines and other immunotherapies, with particular interests in dendritic cell biology, biomaterial-assisted immune modulation, and novel approaches for antigen delivery and immune activation. We also investigate tumor-associated metabolic and microenvironmental pathways that may influence cancer progression and anti-tumor immunity. Our clinically driven research aims to rationalize cancer treatment and improve supportive care for companion animals with cancer. Across these areas, we leverage naturally occurring cancers in companion animals to address clinically relevant questions and generate discoveries with broader translational potential.
Therapeutic Cancer Vaccines
-
DC Homing Biomaterials
Integrating stereotactic body radiation therapy (SBRT) and dendritic cell (DC)-homing material for the development of an in situ cancer vaccine platform
Diverse Therapeutic and Diagnostic Approaches
-
Metronomic Chlorambucil Trial
Investigating the effect of metronomic chlorambucil on regulatory T cells and tumor vasculature in dogs
Collaborators
Collaborations are essential to accelerate scientific discoveries. Dr. Berry has active collaborative projects with the following investigators:
Tim Fan
Paul Hergenrother
Hua Wang
Kari Foss
Arnon Gal
Jennifer Reinhart Dungar
